The pharmaceutical industry has deeply contributed to human welfare. Indeed, new drug enforcement has played a vital role in increasing longevity and enhancing the quality of life. For this reason, issues of justice are particularly sharp, especially concerning the accessibility of drugs to the people who desperately need them.
The question that is raised is whether the drug market should be completely free or be subject to state intervention and if the answer to the question is the second option, it is then necessary to analyse which is the most efficient and right way to intervene. This article focuses on the role of intellectual property rights and patents in the development and accessibility of new pharmaceuticals.